V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005559 | 290004031 | 1.66 | 58.6 | Curative (C) | 2016-08-22 | 2016-08-28 | Docetaxel 75mg/m2 (21 day) | 2 | Y | 290021968 | CAPECITABINE + CISPLATIN |
| 290005560 | 290004032 | 1.45 | 90.8 | Adjuvant (A) | 2016-04-13 | 2016-04-18 | CAPECITABINE + RT | N | N | 290021982 | CAPECITABINE |
| 290005561 | 290006705 | null | null | Adjuvant (A) | 2016-08-31 | 2016-08-31 | Cetuximab + CISPLATIN + FLUOROURACIL | N | Y | 290022114 | CARBO + FLUOROURACIL |
| 290005562 | 290004033 | 1.75 | 69.1 | Curative (C) | 2016-08-24 | 2016-09-17 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290022133 | CETUXIMAB + RT |
| 290005563 | 290006706 | 1.6 | 61 | Neo-adjuvant (N) | 2016-02-11 | 2016-02-11 | CISPLATIN + FLUOROURACIL | 02 | N | 290022157 | SUNITINIB |
| 290005564 | 290004034 | 1.56 | null | Palliative (P) | 2016-12-16 | 2017-01-13 | Cisplatin + Vinorelbine (IV) | N | N | 290022209 | ECX |
| 290005565 | 290004034 | 1.7 | null | Adjuvant (A) | 2017-02-02 | 2017-02-13 | Capecitabine 42days + RT | 2 | N | 290022209 | OCTREOTIDE |
| 290005566 | 290004035 | 1.43 | 93 | Neo-adjuvant (N) | 2016-09-04 | 2016-09-28 | Capecitabine | 02 | Y | 290022316 | GEMCARBO |
| 290005567 | 290004035 | null | 81.2 | Palliative (P) | 2017-10-31 | 2018-03-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 290022316 | EOX |
| 290005568 | 290004036 | 1.77 | 118 | Curative (C) | 2014-09-12 | 2014-09-12 | CHOP R - 21 days | 2 | N | 290022572 | CARBOPLATIN + RT |
| 290005569 | 290004036 | null | null | Palliative (P) | 2018-12-10 | 2018-12-17 | LANREOTIDE | N | N | 290022572 | OCTREOTIDE |
| 290005570 | 290007820 | 0 | 57.7 | Adjuvant (A) | 2014-09-29 | 2014-09-29 | LANREOTIDE | 01 | N | 290022792 | CAPECITABINE + RT |
| 290005571 | 290007820 | 1.8 | 70.3 | Curative (C) | null | 2015-11-01 | Folfirinox | N | N | 290022792 | LANREOTIDE |
| 290005572 | 290004037 | 1.55 | 54 | Adjuvant (A) | 2016-06-11 | 2015-12-17 | Cytarabine Low Dose | null | N | 290022881 | EOX |
| 290005573 | 290004038 | null | 97 | Palliative (P) | 2017-04-06 | 2017-04-27 | Gemcitabine + Methylprednisolone | N | N | 290022903 | TRIAL |
| 290005574 | 290004039 | 1.6 | null | Neo-adjuvant (N) | 2015-03-26 | 2015-04-08 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | 290022907 | BALLAD TRIAL |
| 290005575 | 290004040 | null | null | Disease modification (D) | 2018-01-09 | 2018-01-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022921 | OCTREOTIDE |
| 290005576 | 290004041 | 1.81 | null | Neo-adjuvant (N) | 2014-04-29 | 2014-04-29 | LANREOTIDE | 02 | N | 290022996 | OCTREOTIDE |
| 290005577 | 290004042 | 1.64 | null | Adjuvant (A) | 2019-05-24 | 2018-10-27 | ECX | null | null | 290023000 | RITUXIMAB |
| 290005578 | 290004043 | 1.8 | 80 | Curative (C) | 2014-03-27 | 2014-04-16 | Capecitabine | 2 | N | 290023089 | PACLITAXEL |
| 290005579 | 290004044 | 0 | 77.8 | Neo-adjuvant (N) | 2017-03-14 | 2017-03-26 | Capecitabine | 02 | N | 290023093 | CAPECITABINE |
| 290005580 | 290004044 | 1.65 | 56.8 | Disease modification (D) | 2018-12-30 | 2019-01-30 | OCTREOTIDE | N | N | 290023093 | CARBOPLATIN + ETOPOSIDE |
| 290005581 | 290004045 | null | null | Palliative (P) | 2019-03-09 | 2019-03-10 | Cisplatin + Etoposide po&iv 3 day | null | N | 290023176 | CAPECITABINE + CISPLATIN + RT |
| 290005582 | 290004045 | 1.62 | 51.2 | Adjuvant (A) | null | 2017-06-16 | OCTREOTIDE | 02 | null | 290023176 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005583 | 290004046 | 1.51 | 69.1 | Palliative (P) | 2016-01-10 | 2016-01-16 | OCTREOTIDE | 2 | null | 290023262 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005584 | 290004047 | 1.65 | 61.8 | Curative (C) | 2017-12-17 | 2017-12-24 | Capecitabine + Cisplatin | N | Y | 290023306 | GEMCARBO |
| 290005585 | 290004047 | 1.62 | 58.9 | Palliative (P) | 2017-05-27 | 2017-05-27 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 290023306 | CETUXIMAB |
| 290005586 | 290004048 | 1.64 | null | Palliative (P) | 2015-12-12 | 2015-12-14 | LANREOTIDE | N | N | 290023418 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 290005587 | 290004049 | 1.6 | 62 | Palliative (P) | 2018-05-23 | 2018-05-24 | CAPECITABINE + RT | null | null | 290023438 | CARBO + FLUOROURACIL |
| 290005588 | 290006713 | 1.77 | 74 | Palliative (P) | 2016-12-30 | 2017-01-09 | Capecitabine 35days + RT | N | N | 290023442 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290005589 | 290006713 | 1.6 | 87.6 | Palliative (P) | 2013-07-30 | 2013-08-11 | Irinotecan + Modified De Gramont | 02 | N | 290023442 | TRIAL |
| 290005590 | 290004050 | 1.64 | 81 | Curative (C) | 2016-06-12 | 2016-06-12 | CARBOPLATIN + ETOPOSIDE | N | null | 290023609 | PLATO TRIAL |
| 290005591 | 290004051 | null | null | Palliative (P) | 2016-08-15 | 2016-09-04 | Cisplatin +Fluorouracil (3 wk) | null | N | 290023660 | FLUOROURACIL |
| 290005592 | 290004052 | 1.47 | 45.5 | Palliative (P) | 2016-07-19 | 2016-07-19 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 290023695 | CISPLATIN + FLUOROURACIL |
| 290005593 | 290004052 | null | 62.7 | Neo-adjuvant (N) | 2013-09-26 | 2013-10-16 | CHOP R - 21 days | 02 | N | 290023695 | IDARUBICIN |
| 290005594 | 290004053 | 1.55 | 71 | Neo-adjuvant (N) | 2015-11-23 | 2015-12-02 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290023736 | CAPECITABINE |
| 290005595 | 290004054 | 1.63 | 44.1 | Curative (C) | 2018-01-24 | 2018-02-10 | Mitomycin Intravesical | 02 | null | 290023787 | FLUOROURACIL |
| 290005596 | 290004055 | 1.73 | 77.5 | Curative (C) | 2017-09-23 | 2017-09-23 | CARBOPLATIN + RT | Y | N | 290023863 | BENDAMUSTINE + RITUXIMAB |
| 290005597 | 290004055 | null | null | Palliative (P) | 2019-01-16 | 2019-01-29 | LANREOTIDE | 02 | N | 290023863 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005598 | 290004056 | 1.63 | 0 | Adjuvant (A) | 2015-12-10 | 2015-12-14 | MITOMYCIN | 2 | N | 290023918 | CISPLATIN + FLUOROURACIL |
| 290005599 | 290004056 | 1.74 | 66.4 | Not known (9) | 2017-09-11 | 2017-09-11 | OXALIPLATIN | N | null | 290023918 | CARBOPLATIN + ETOPOSIDE |
| 290005600 | 290004056 | null | null | Palliative (P) | 2014-01-18 | 2014-01-28 | CETUXIMAB | N | null | 290023918 | LANREOTIDE |
| 290005601 | 290004057 | 1.67 | 97 | Neo-adjuvant (N) | 2018-01-19 | 2018-01-27 | Cisplatin +Fluorouracil (3 wk) | N | N | 290024091 | CAPECITABINE + TEMOZOLOMIDE |
| 290005602 | 290004058 | null | 97.8 | Palliative (P) | 2016-12-20 | 2017-01-02 | CETUXIMAB | 02 | Y | 290024141 | RITUXIMAB |
| 290005603 | 290004059 | 1.8 | 68.6 | Palliative (P) | 2017-06-03 | 2017-06-16 | Bevacizumab + Oxaliplatin +MdG | N | N | 290024165 | CISPLATIN + FLUOROURACIL |
| 290005604 | 290004060 | 1.75 | 99.9 | Curative (C) | 2016-06-19 | 2016-06-25 | Docetaxel | N | N | 290024230 | CAPECITABINE |
| 290005605 | 290004061 | null | 58.6 | Disease modification (D) | 2017-10-31 | 2017-12-13 | Folfirinox | N | N | 290024251 | CAPECITABINE + RT |
| 290005606 | 290004061 | null | 39.1 | Palliative (P) | 2016-06-14 | 2016-06-26 | Carbo F | null | N | 290024251 | BALLAD TRIAL |
| 290005607 | 290004061 | 1.6 | 67.2 | Palliative (P) | 2017-04-01 | 2017-04-07 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 290024251 | CISPLATIN + FLUOROURACIL |
| 290005608 | 290004062 | 1.57 | 61.5 | null | 2016-08-06 | 2016-08-26 | Everolimus 10mg | 02 | Y | 290024325 | CAPECITABINE + GEMCITABINE |